Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Leoclan CoTSE:7681 66 Market Cap is 円5,655 Mil as of Aug. 03, 2026. GuruFocus rates TSE:7681 with a GF Score™ of 66/100 and a GF Value™ of 円1,290.91 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 121 Medical Distribution companies, Leoclan Co ranks worse than 71.9% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Leoclan Co's share price for the quarter that ended in Mar. 2026 was 円915. Leoclan Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 6 Mil. Therefore, Leoclan Co's market cap for the quarter that ended in Mar. 2026 was 円5,419 Mil.
Leoclan Co's quarterly market cap
increased
from Mar. 2025 (円6,294 Mil) to Sep. 2025 (円6,668 Mil) but then
declined
from Sep. 2025 (円6,668 Mil) to Mar. 2026 (円5,419 Mil).
Leoclan Co's annual market cap
increased
from Sep. 2023 (円5,409 Mil) to Sep. 2024 (円6,080 Mil) and
increased
from Sep. 2024 (円6,080 Mil) to Sep. 2025 (円6,668 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Leoclan Co's Enterprise Value for Today is 円3,309 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Leoclan Co Market Cap Related Terms
Leoclan Co Market Cap Historical Data
* Premium members only.
The historical data trend for Leoclan Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Leoclan Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leoclan Co Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Leoclan Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Leoclan Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Leoclan Co's Market Cap for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leoclan Co (TSE:7681) has a Market Cap of 円5,655 Mil as of Aug. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Leoclan Co and its competitors. According to the industry distribution chart, Leoclan Co ranks #87 out of 121 companies in the Medical Distribution industry, placing it in the top 71.9%.
Is Leoclan Co's Market Cap too high?
Leoclan Co's current Market Cap is 円5,655 Mil. Based on the distribution chart, Leoclan Co ranks #87 out of 121 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Leoclan Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Leoclan Co's Market Cap compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Leoclan Co ranks #87 out of 121 companies for Market Cap. This places Leoclan Co in the lower half of its industry. The industry median Market Cap is 143.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 143.55, based on 121 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Leoclan Co and its competitors. For the Medical Distribution industry, the median Market Cap is 143.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leoclan Co's current Market Cap is 円5,655 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leoclan Co stock overvalued right now?
Based on GuruFocus' analysis, Leoclan Co (TSE:7681) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,290.91, compared to a current price of 円955.00 — trading 26% below its estimated fair value. The current Market Cap is 円5,655 Mil. Leoclan Co's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Leoclan Co (TSE:7681), the current Market Cap is 円5,655 Mil as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leoclan Co (TSE:7681) Overvalued in 2026?
Based on GuruFocus' analysis, Leoclan Co stock appears to be undervalued.
The current stock price of 円955.00 is trading 26% below its estimated GF Value™ of 円1,290.91.
GuruFocus considers Leoclan Co to be Modestly Undervalued.
Key valuation signals for TSE:7681:
Market Cap: 円5,655 Mil
GF Value™: 円1,290.91 vs. price of 円955.00 (26% below fair value)
No single metric tells the full story. See the TSE:7681 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7681 has been successfully added to your 
